Royalty Pharma plc
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $471.1M | $471.1M | — | $0 |
| Jun 2020 | $489.0M | $489.0M | — | $3.7M |
| Sep 2020 | $508.8M | $508.8M | — | $848.0K |
| Dec 2020 | $565.7M | $565.7M | — | $840.0K |
| Mar 2021 | $526.1M | $526.1M | — | $713.0K |
| Jun 2021 | $531.7M | $531.7M | — | $721.0K |
| Sep 2021 | $469.8M | $469.8M | — | $505.0K |
| Dec 2021 | $490.0M | $490.0M | — | $504.0K |
| Mar 2022 | $460.3M | $460.3M | — | $496.0K |
| Jun 2022 | $575.0M | $575.0M | — | $509.0K |
| Sep 2022 | $538.8M | $538.8M | — | $582.0K |
| Dec 2022 | $569.9M | $569.9M | — | $583.0K |
| Mar 2023 | $1.03B | $1.03B | — | $573.0K |
| Jun 2023 | $607.8M | $607.8M | — | $586.0K |
| Sep 2023 | $573.5M | $573.5M | — | $581.0K |
| Dec 2023 | $772.6M | $772.6M | — | $617.0K |
| Mar 2024 | $664.6M | $664.6M | — | $612.0K |
| Jun 2024 | $658.2M | $658.2M | — | $681.0K |
| Sep 2024 | $703.6M | $703.6M | — | $526.0K |
| Dec 2024 | $742.5M | $742.5M | — | $525.0K |
| Mar 2025 | $596.1M | $596.1M | — | $515.0K |
| Jun 2025 | $364.0M | $364.0M | — | $90.8M |
| Sep 2025 | $702.6M | $702.6M | — | $72.8M |
| Dec 2025 | $827.1M | $827.1M | — | $125.8M |
| Mar 2026 | $718.2M | $718.2M | — | $122.0M |
| Jun 2026 | $728.5M | $728.5M | — | $107.1M |